These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9836381)

  • 21. Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration.
    Reiter C; Kakavand B; Rieber EP; Schattenkirchner M; Riethmüller G; Krüger K
    Arthritis Rheum; 1991 May; 34(5):525-36. PubMed ID: 2025306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Future use of biologic agents alone and in combination for the treatment of rheumatoid arthritis.
    Strand V
    Z Rheumatol; 1998 Feb; 57(1):41-5. PubMed ID: 9566107
    [No Abstract]   [Full Text] [Related]  

  • 23. A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis.
    van der Lubbe PA; Dijkmans BA; Markusse HM; Nässander U; Breedveld FC
    Arthritis Rheum; 1995 Aug; 38(8):1097-106. PubMed ID: 7639806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis.
    Williams RO; Mason LJ; Feldmann M; Maini RN
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2762-6. PubMed ID: 7908442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis.
    Tak PP; van der Lubbe PA; Cauli A; Daha MR; Smeets TJ; Kluin PM; Meinders AE; Yanni G; Panayi GS; Breedveld FC
    Arthritis Rheum; 1995 Oct; 38(10):1457-65. PubMed ID: 7575695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CAMPATH-1H in inflammatory arthritis.
    Watts RA; Isaacs JD; Hale G; Hazleman BL; Waldmann H
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S165-7. PubMed ID: 8324942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease.
    Riethmüller G; Rieber EP; Kiefersauer S; Prinz J; van der Lubbe P; Meiser B; Breedveld F; Eisenburg J; Krüger K; Deusch K
    Immunol Rev; 1992 Oct; 129():81-104. PubMed ID: 1464423
    [No Abstract]   [Full Text] [Related]  

  • 28. An anti-CD4 antibody for treatment of chronic inflammatory arthritis.
    Emmrich F; Horneff G; Becker W; Lüke W; Potocnik A; Kanzy U; Kalden JR; Burmester G
    Agents Actions Suppl; 1991; 32():165-70. PubMed ID: 2069085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological insights from clinical trials with anti-TNF therapy.
    Feldmann M; Charles P; Taylor P; Maini RN
    Springer Semin Immunopathol; 1998; 20(1-2):211-28. PubMed ID: 9836378
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients.
    Goldberg D; Morel P; Chatenoud L; Boitard C; Menkes CJ; Bertoye PH; Revillard JP; Bach JF
    J Autoimmun; 1991 Aug; 4(4):617-30. PubMed ID: 1777012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of intra-articular primatised anti-CD4 in resistant rheumatoid knees.
    Smith M
    Ann Rheum Dis; 2000 May; 59(5):398-9. PubMed ID: 10836958
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis.
    Horneff G; Sack U; Kalden JR; Emmrich F; Burmester GR
    Clin Exp Immunol; 1993 Feb; 91(2):207-13. PubMed ID: 7679058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological therapies: a novel approach to the treatment of autoimmune disease.
    Fox DA
    Am J Med; 1995 Jul; 99(1):82-8. PubMed ID: 7598148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
    Feldmann M; Maini RN
    Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunomodulating therapy of rheumatoid arthritis (chronic polyarthritis): use of monoclonal antibodies].
    Horneff G; Burmester GR
    Z Rheumatol; 1995; 54(2):96-104. PubMed ID: 7540786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New therapeutic approaches in autoimmune rheumatic diseases, with special emphasis on rheumatoid arthritis.
    Kalden JR; Manger B
    Br J Rheumatol; 1995 Mar; 34(3):193-6. PubMed ID: 7728390
    [No Abstract]   [Full Text] [Related]  

  • 37. TNF-alpha-targeted therapy in rheumatoid arthritis.
    Wendling D; Toussirot E
    Rev Rhum Engl Ed; 1999 Apr; 66(4):187-91. PubMed ID: 10339773
    [No Abstract]   [Full Text] [Related]  

  • 38. Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.
    Isaacs JD; Burrows N; Wing M; Keogan MT; Rebello PR; Watts RA; Pye RJ; Norris P; Hazelman BL; Hale G; Waldmann H
    Clin Exp Immunol; 1997 Nov; 110(2):158-66. PubMed ID: 9367397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TNF receptor fusion protein in rheumatoid arthritis.
    O'Brien C
    Mol Med Today; 1996 Jul; 2(7):269. PubMed ID: 8796900
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoclonal antibody therapy in rheumatoid arthritis.
    Choy EH; Kingsley GH; Panayi GS
    Br J Rheumatol; 1998 May; 37(5):484-90. PubMed ID: 9651073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.